Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 325 | 252 | 0 |
| Operating Income | -325 | -252 | N/A |
| Other Income | -4 | -4 | 0 |
| Pre-tax Income | -329 | -256 | 0 |
| Net Income Continuous | -329 | -256 | N/A |
| Net Income | $-329 | $-256 | $N/A |
| EPS Basic Total Ops | -0.03 | -0.02 | N/A |
| EPS Basic Continuous Ops | -0.03 | -0.02 | N/A |
| EPS Diluted Total Ops | -0.03 | -0.02 | N/A |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | N/A |
| EBITDA(a) | $-325 | $-252 | $N/A |